Stemnovate Next-Gen Platforms
Drug Discovery Platform
We use novel multi-organ modelling to evaluate drug molecule metabolism and toxicity, ensuring better clinical trials and patient safety outcomes. Our projects include Hepatitis research and many more.
Our work on automation for cell based assays save cost and time and revolutionize the pharmaceutical industry.
Ethical sourcing is core to our biobank, reflecting human diversity in age, gender & ethnicities. We are experts in cellular reprogramming with the capability for human and animal reprogramming.
For industry and academia, we routinely differentiate stem cells into the liver, heart, and neuronal cells.
Molecular & Microengineering
We design vectors with an industrial process to generate induced pluripotent stem cell In addition, we offer a multispecies cell platform ensuring quality through advanced profiling and bioinformatics.
We provide digitaland for disease profiling and understanding drug metabolism response.
The drug discovery data often cannot be reproduced with conventional techniques. Therefore, we integrate computational modelling and microengineering to enable next-gen drug development.
Stemnovate aims to make precision medicine a global reality through unique data platforms and novel devices.
Our global partnerships include top-tier pharmaceutical companies and world-renowned academia. We often partner with institutes for industrial PhD studentships, such as the
National Physical Laboratory, the University of Edinburgh, the University of Northumbria, and the Babraham Institute, to name a few.
TALE OF TWIN CITIES: CAMBRIDGE FOR STEM CELL RESEARCH
Cambridge has an excellent ecosystem for biotech, espaicially working in the stem cell research space to thrive.
Please read our latest blog and be part of community.
The experts at Stemnovate gave helpful advice and continue to show an interest in our work – a refreshing change to deal with such a professional and knowledgeable company